mounjaro tirzepatide brand name Lilly's Weight-Loss Drug Approved in China Amid Race With Novo Mounjaro Tirzepatide Injection 2.5mg, 7.5

Compounded Semaglutide has not been reviewed or approved by the FDA for safety, efficacy, or quality

Key Takeaways Semaglutide acts only on GLP-1 receptors, while tirzepatide targets both GLP-1 and GIP, a dual mechanism that sets them apart

Several injection errors can compromise tirzepatide effectiveness or increase the risk of adverse effects

Comparison Whats the Difference Between Tirzepatide and Semaglutide

Alternative pharmacotherapy options include other GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or dulaglutide (Trulicity), which share similar mechanisms and may be more affordable or accessible